STAT

Opinion: Faster concussion diagnoses are on the horizon. Patent filings offer a peek

Companies trying to develop new ways to diagnose a concussion aim to meet the same design requirements — fast, accessible, and objective tests that can be deployed immediately where the…
Companies are exploring a variety of ways to more rapidly diagnose the 3.8 million concussions that occur each year as a result of sports and recreational activities.

Exactly what repeated concussions do to the brain is a hotly debated question at the forefront of national discussion. The billion-dollar settlement with the National Football League and landmark studies about the prevalence of a serious form of brain damage known as chronic traumatic encephalopathy among NFL athletes have alarmed many that the demise of American football — all the way from the professional level to youth sports — may be on the horizon.

In the United States, an estimated occur each year during competitive sports and recreational activities. It is difficult, if not impossible, to accurately diagnose these injuries immediately after they occur. Rapid detection is important because an athlete suspected of having a concussion should immediately stop playing, seek medical attention, and rest until symptoms subside completely.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks